Senior Global Market Access Lead

Novo Nordisk India Pvt Ltd; Bengaluru; On-site; INR 4,000,000 - 7,000,000; Full time

Job summary

Novo Nordisk India Pvt Ltd in Bangalore is seeking a Senior Global Market Access Lead to own asset-level market access and payer value strategy across obesity assets from pipeline to lifecycle. You will integrate payer insights, HTA strategy, and value communication to influence how therapies reach patients across 194 countries.

The role involves leading TAP development, market access business cases, and global payer toolsets, while shaping HTA submissions and cross-functional collaboration.

Qualifications

• Master's degree or higher in Health Economics, Public Health, Pharmacy or related field.
• 6–10 years of asset-level market access experience with payer research and HTA planning.
• Strong knowledge of payer systems, HTA processes, and reimbursement pathways.
• Proven ability to develop TAPs and payer value narratives integrating pricing and evidence.

Responsibilities

• Own asset-level market access and payer value strategy across pipeline, launch, and lifecycle stages.
• Lead development of TAPs, market access business cases, and global payer toolsets with cross-functional teams.
• Shape HTA and reimbursement strategy packages, including submission sequencing and risk assessments.
• Provide market access input into clinical development planning and early access strategy.
• Drive payer insight generation to inform access strategy and evidence needs.
• Coordinate cross-functional stakeholders across Clinical, Medical, Commercial, Regulatory, and affiliates.
• Lead internal and affiliate training on asset-specific access strategy and mentor team members.

Skills

Market access

TAP development

HTA planning

Payer engagement

Global matrix

Stakeholder management

English communication

Education

Master's degree or higher in Health Economics or related field

Tools

eCVDs

Value decks

Negotiation toolkits

Job description

Sr Global Market Access Lead Team: Global Market Access and Pricing – Obesity& Access, Product & Portfolio Strategy Location: Bangalore, Novo Nordisk Global Business Services (GBS), India Shape how millions of people gain access to the next generation of Obesity & Liver therapies. In this role, you will own asset-level market access and payer value strategy at a defining moment for Novo Nordisk – translating science into reimbursement reality across the globe.

Your new role

As Senior Global Market Access Lead, you will own and drive market access and payer value strategy across pipeline, launch, and lifecycle stages for assigned obesity assets. Operating with high independence, you will integrate payer insight, HTA strategy, and value communication into the heart of asset development - influencing how our therapies reach patients in 194 countries.

Day-to-day, your responsibilities will include:

• Owning asset-level market access and payer value strategy, integrating payer research, Target Access Profile (TAP), and access risk assessment across pipeline, launch, and lifecycle stages
• Leading the development and refinement of TAPs, market access business cases, and global payer value communication toolsets (eCVDs, value decks, negotiation toolkits) in collaboration with Pricing and HEOR
• Shaping HTA and reimbursement strategy packages, including submission sequencing plans, risk assessments, and high-complexity affiliate support for HTA submissions, payer negotiations, and objection handling
• Providing market access input into clinical development planning, including early access strategy, HTA risk assessment, and evidence needs
• Driving payer insight generation to inform access strategy, value messaging, and evidence requirements
• Acting as informal market access matrix lead for assigned assets - coordinating cross-functional stakeholders across Clinical, Medical, Commercial, Regulatory, and affiliate teams
• Leading internal and affiliate-facing training on asset-specific access strategy and payer value communication, and mentoring junior and mid-level colleagues across the team

Your new department

In Product & Portfolio Strategy we drive commercial strategy, medical affairs and business devel-opment across all therapy areas. We act as a connector and compass, guiding the new Novo Nordisk portfolio for sustained competitiveness upstream, and maximising portfolio potential through successful commercial strategies and competitive launches downstream. You will join Global Market Access and Pricing – Obesity& Access, the team responsible for de-fining, shaping, and operationalising payer-relevant value and access strategies across the asset lifecycle. We work at the intersection of science, evidence, and health systems - partnering close-ly with HEOR, Pricing, Payer Evidence, Clinical Development, Medical, Commercial, and region-al/affiliate teams to ensure payer insights and access strategy are embedded into pipeline development, launch preparation, and lifecycle management.

Your skills & qualifications

• A Master's degree or higher in Health Economics, Public Health, Pharmacy, Epidemiology, Biostatistics, Health Services Research, or a closely related quantitative/health discipline, with formal training or demonstrated experience in Market Access, Value Strategy, Payer Engagement, or Health Economics
• 6-10 years of relevant experience with clear ownership of asset-level market access strategy, including payer research, TAP development, HTA planning, and launch preparation
• Strong understanding of payer systems, HTA processes, and reimbursement pathways across key markets, combined with knowledge of payer research methods and the ability to translate insight into coherent access strategy
• Demonstrated ability to develop and refine TAPs, market access business cases, and pay-er value narratives - integrating pricing, HEOR, and payer evidence inputs into a single, defensible story
• Proven success operating in a global matrix environment, with advanced stakeholder management, strong project leadership, and excellent written and verbal communication skills in English
• Sound judgement in balancing access ambition with evidence readiness and launch constraints, and the personal resilience to navigate shifting payer feedback and strategic priorities

The role is global in scope, with up to 5% international travel and virtual collaboration across time zones.

Experience Level

Senior Level

What we offer

There is, of course, more on offer here than the uniqueness of our culture and the extraordinary results we produce. Being part of a global healthcare company means opportunities to learn and develop are all around us, while our benefits are designed with your career and life stage in mind.

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

Deadline 10 Nov 2026.